BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26716518)

  • 1. STAT5 in Cancer and Immunity.
    Rani A; Murphy JJ
    J Interferon Cytokine Res; 2016 Apr; 36(4):226-37. PubMed ID: 26716518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B.
    Hennighausen L; Robinson GW
    Genes Dev; 2008 Mar; 22(6):711-21. PubMed ID: 18347089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between STAT5 activation and PI3K/AKT functions in normal and transformed mammary epithelial cells.
    Rädler PD; Wehde BL; Wagner KU
    Mol Cell Endocrinol; 2017 Aug; 451():31-39. PubMed ID: 28495456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines.
    Lin JX; Leonard WJ
    Oncogene; 2000 May; 19(21):2566-76. PubMed ID: 10851055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transducer and activator of transcription 5 (STAT5), a crucial regulator of immune and cancer cells.
    Wittig I; Groner B
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Dec; 5(4):449-63. PubMed ID: 16375697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the STAT5 signaling pathway in the regulation of mouse preimplantation development.
    Nakasato M; Shirakura Y; Ooga M; Iwatsuki M; Ito M; Kageyama S; Sakai S; Nagata M; Aoki F
    Biol Reprod; 2006 Oct; 75(4):508-17. PubMed ID: 16775227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT5 isoforms regulate colorectal cancer cell apoptosis via reduction of mitochondrial membrane potential and generation of reactive oxygen species.
    Du W; Wang YC; Hong J; Su WY; Lin YW; Lu R; Xiong H; Fang JY
    J Cell Physiol; 2012 Jun; 227(6):2421-9. PubMed ID: 21826656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3 and STAT5 Signaling Thresholds Determine Distinct Regulation for Innate Receptor-Induced Inflammatory Cytokines, and
    Hedl M; Sun R; Huang C; Abraham C
    J Immunol; 2019 Dec; 203(12):3325-3338. PubMed ID: 31732533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Roles of STAT5 in hematopoietic regulation and blood diseases].
    Zhao YZ; Yuan WP; Cheng T
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1496-500. PubMed ID: 23257461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF-1 stimulated upregulation of cyclin D1 is mediated via STAT5 signaling pathway in neuronal cells.
    Kalita A; Gupta S; Singh P; Surolia A; Banerjee K
    IUBMB Life; 2013 May; 65(5):462-71. PubMed ID: 23504816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and use of constitutively active STAT5 constructs.
    Farrar MA
    Methods Enzymol; 2010; 485():583-96. PubMed ID: 21050937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive activation of Stat5b contributes to carcinogenesis in vivo.
    Xi S; Zhang Q; Gooding WE; Smithgall TE; Grandis JR
    Cancer Res; 2003 Oct; 63(20):6763-71. PubMed ID: 14583472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stat5 activation inhibits prolactin-induced AP-1 activity: distinct prolactin-initiated signals in tumorigenesis dependent on cell context.
    Gutzman JH; Rugowski DE; Nikolai SE; Schuler LA
    Oncogene; 2007 Sep; 26(43):6341-8. PubMed ID: 17438530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complex roles of STAT3 and STAT5 in maintaining redox balance: Lessons from STAT-mediated xCT expression in cancer cells.
    Linher-Melville K; Singh G
    Mol Cell Endocrinol; 2017 Aug; 451():40-52. PubMed ID: 28202313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a.
    Piekorz RP; Hocke GM
    Cytokine; 1997 Sep; 9(9):639-49. PubMed ID: 9325012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.
    Nagy ZS; Wang Y; Erwin-Cohen RA; Aradi J; Monia B; Wang LH; Stepkowski SM; Rui H; Kirken RA
    J Leukoc Biol; 2002 Oct; 72(4):819-28. PubMed ID: 12377952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential function of STAT5 isoforms in head and neck cancer growth control.
    Leong PL; Xi S; Drenning SD; Dyer KF; Wentzel AL; Lerner EC; Smithgall TE; Grandis JR
    Oncogene; 2002 Apr; 21(18):2846-53. PubMed ID: 11973644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells.
    Barclay JL; Anderson ST; Waters MJ; Curlewis JD
    Mol Endocrinol; 2007 Oct; 21(10):2503-15. PubMed ID: 17609438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.
    Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M
    Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STATs in cancer inflammation and immunity: a leading role for STAT3.
    Yu H; Pardoll D; Jove R
    Nat Rev Cancer; 2009 Nov; 9(11):798-809. PubMed ID: 19851315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.